Company / FCF Margin
aTYR PHARMA INC FCF Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-32664.7%
FY2025
5-year range
-32664.7% / -148.3%
FY2021-FY2025
Trend
-11.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -148.3% to -32664.7% over the past 3 years.
Based on SEC 10-K filings.
-32664.7% in FY2025 with a 5-year CAGR of -25163.1%.
Declined from -148.3% to -32664.7% over the past 3 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -32516.5pp
- 5-Year Change
- -25163.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 11.0% year-over-year.
- Peak fcf margin was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -32664.7% | -11.0% |
| FY2024 | -29440.0% | - |
| FY2023 | - | - |
| FY2022 | -148.3% | +96.9% |
| FY2021 | -4761.1% | +36.5% |
| FY2020 | -7501.7% | +27.5% |
| FY2019 | -10349.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026